Phio Pharmaceuticals Corp. (PHIO)
Market Closed
11 Jun, 20:00
NASDAQ (CM) NASDAQ (CM) Primary 
XMUN $
1. 08
+0.02
+1.8868%
$
13.24M Market Cap
- P/E Ratio
- Div Yield
175,545 Volume
-5.62 Eps
$ 1.06
Previous Close Want to track PHIO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Phio Pharmaceuticals Corp. (PHIO) Statistics
Valuation metrics
Market Cap 13.24M
Enterprise value -4.72M
Trailing P/E (ttm) -1.13
Forward P/E -1.24
PEG ratio -0.01
Price/Sales (ttm) -
Price/Book (mrq) 0.75
Enterprise Value/Revenue -
Enterprise Value/EBITDA 0.41
Overview
Shares outstanding 11.62M
Float 11.55M
Shares short 469.57K
% Held by insiders 0.06%
% Held by institutions 0.11%
Average volume (10 days) 123.88K
Average volume (90 days) 201.59K
Price summary
52-Week low 0.81
52-Week high 4.19
Beta 0.91
50-Day moving average 1.15
200-Day moving average 1.16
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:9
Last split Date 5 Jul 2024
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.63%
Return on equity -0.77%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -4.62M
EBITDA -11.51M
Net income to common (ttm) -10.93M
Diluted EPS (ttm) -0.94
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 17.03M
Total cash per share (mrq) 1.47
Total debt (mrq) -
Total Debt/Equity (mrq) -
Current ratio (mrq) 66.93%
Book value per share (mrq) 1.42
Cash Flow
Cash flow statement -10.71M
Levered free cash flow (LFCF) -7.25M
